title: 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.
authors.affiliation: Department of Neurology , University Hospital, Basel, Switzerland. mehlingm@uhbs.ch
authors.forename: Matthias
authors.initials: M
authors.lastname: Mehling
authors.forename: Jens
authors.initials: J
authors.lastname: Kuhle
authors.forename: Axel
authors.initials: A
authors.lastname: Regeniter
mesh_terms: D001323:Autoantibodies / Q000032:analysis / Q000134:cerebrospinal fluid; D015551:Autoimmunity / Q000276:immunology; D015415:Biomarkers / Q000032:analysis / Q000134:cerebrospinal fluid; D002555:Cerebrospinal Fluid / Q000276:immunology*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis / Q000276:immunology*; D003937:Diagnosis, Differential; D003951:Diagnostic Errors / Q000517:prevention & control*; D006801:Humans; D007958:Leukocyte Count; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000276:immunology; D043025:Oligoclonal Bands / Q000032:analysis / Q000134:cerebrospinal fluid
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D002556:Cerebrospinal Fluid Proteins; D043025:Oligoclonal Bands